John Drakenberg

John Drakenberg is the Founder and CEO of Alex Therapeutics, a digital therapeutics company based in Stockholm, Sweden. He co-founded the company in 2018 with Oliver Fleetwood, aiming to democratize healthcare through the integration of psychology, design, and technology. Drakenberg holds degrees in both Psychology and Business, which underpin his approach to creating patient-centric healthcare solutions.12

Professional Background

Before establishing Alex Therapeutics, Drakenberg founded Arista Education in 2005. His entrepreneurial journey is characterized by a commitment to improving mental health care accessibility and effectiveness. Under his leadership, Alex Therapeutics has developed the Alex DTx Platform, which utilizes artificial intelligence and evidence-based psychological practices, particularly Cognitive Behavioral Therapy (CBT), to deliver personalized digital therapies.34

Mission and Impact

Alex Therapeutics focuses on providing high-quality, digitally delivered care to address behavioral health issues. The company has successfully partnered with major pharmaceutical firms like Pfizer to develop clinically validated digital interventions.23 With a team of over 20 professionals, including psychologists and engineers, they aim to reach millions globally, enhancing treatment accessibility and personalization.2

Community Engagement

In addition to his role at Alex Therapeutics, Drakenberg is active in mentoring aspiring entrepreneurs through various programs, sharing insights on startup development and innovation in health technology.13